Your experience in treating a broad spectrum of illnesses contributes to improving patient care and advancing new therapeutic solutions.
Are you a physician who regularly prescribes medication? We invite you to discover our study opportunities.
The content is specifically tailored to your field of expertise. Key areas of focus include:
Physicians from almost all specialties are welcome. The time required per study typically ranges from 10 to 60 minutes.
One-off surveys: These studies focus on examining a specific condition or its perception.
Tracking studies: Regularly recurring studies to capture:
The questionnaires used remain unchanged. Data collection is carried out at fixed intervals; monthly, quarterly, or annually.
Examples of typical study focus areas: Autoimmune diseases treated with biologics, multiple myeloma, non-small cell lung cancer, prostate cancer
These studies are usually conducted online, by phone, or via video call.
Group discussions: Physicians share insights on specific topics, such as the treatment of non-alcoholic fatty liver disease or childhood myopia.
In-depth interviews: One-on-one conversations with trained moderators about diseases and current or future treatment approaches.
These studies aim to identify, characterize, and evaluate potential risks to patient safety.
They help confirm the safety profile of approved medicines and assess the effectiveness of risk management measures.
This helps provide a comprehensive understanding of a medicine's safety throughout the post-marketing phase.
The purpose of these studies is to identify leading experts in specific medical or scientific fields and to gain deeper insights into their relevance and influence within the professional community.
At IQVIA, research studies are subject to strict regulations to protect participants and ensure the integrity of the data collected.
This framework is essential to guarantee transparency, compliance with legal requirements, and adherence to ethical standards - while at the same time fostering innovation and the development of new therapies.
Your data is anonymized and processed in accordance with GDPR. No identifiable patient data is collected.
Data protection policies and handling of personal data
To ensure that participants fully understand the study’s objectives, methods, risks, and potential benefits, informed consent is essential. It guarantees that participation is voluntary and based on informed decision-making.
To ensure that our studies produce relevant and reliable results, we ask for some information about your background.
This allows us to determine whether the study focus aligns with your expertise and whether key scientific criteria are met.
Your data will be used exclusively to assess study eligibility.
You will receive financial compensation for each study you complete. You can choose from the following options:
If you receive visits from pharmaceutical sales representatives and practice as a general practitioner or medical specialist, we invite you to join our study.
Email: PI-sweden@iqvia.com
Phone:+46317100374
We will follow up with you personally.
.svg){kind=icon}
